In vivo gene therapy for α-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene

Cancer Research

Volumn 57, Issue 3, 1997, Pages 461-465

  Kanai, Fumihiko ^a,b   Lan, Keng Hsin ^a   Shiratori, Yasushi ^a   Tanaka, Torao ^a   Ohashi, Makoto ^a   Okudaira, Takehito ^a   Yoshida, Yoko ^b   Wakimoto, Hiroaki ^b   Hamada, Hirofumi ^b   Nakabayashi, Hidekazu ^c   Tamaoki, Taiki ^c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA GALACTOSIDASE; CYTOSINE DEAMINASE; FLUCYTOSINE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CLONING VECTOR; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUICIDE GENE; TUMOR XENOGRAFT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CYTOSINE DEAMINASE; GENE THERAPY; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NUCLEOSIDE DEAMINASES; TUMOR CELLS, CULTURED;

EID: 0031043426     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Colombo, M. Hepatocellular carcinoma. J. Hepatol., 75:225-236, 1992.
2. Farmer, D. G., and Busuttil, R. W. The role of multimodal thrapy in the treatment of hepatocellular carcinoma. Cancer (Phila.), 73:2669-2670, 1994.
3. Venook, A. P. Treatment of hepatocellular carcinoma: too many options? J. Clin. Oncol., 12: 1323-1334, 1994,
4. Levin, B., and Amos, C. Therapy of unresectable hepatocellular carcinoma. N. Engl. J. Med., 332:1294-1296, 1995.
5. Gutierrez, A. A., Lenioine, N. R., and Sikora, K. Gene therapy for cancer. Lancet, 339:715-721, 1992.
6. Gore, M. E., and Collins, M. K. Gene therapy for cancer. Eur, J. Cancer, 30A:1047-1049, 1994.
7. Anderson, W. F. Gene therapy for cancer. Hum. Gene Ther., 5: 1-2, 1994.
8. Ravoet, C., Bleiberg, H., and Gerard, B. Non-surgical treatment of hepatoma. J. Surg. Oncol., 3:104-111, 1993.
9. Patt, Y. Z., Yoffe, B., Chamsangavej, C., Pazdur, R., Fisher, H., Cleary, K., Roh, M., Smith, R., Noonan, C. A., and Levin, B. Low serum alpha-fetoprotein level in patient with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer (Phila.), 72:2574-2582, 1993.
10. Moolten, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1: 279-287, 1994.
11. Polak, A., and Scholer, H. J. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy, 21:113-130, 1975.
12. Andersen, L., Kilstrup, M., and Neuhard, J. Pyrimidine, purine and nitrogen control of cytosine deaminase synthesis in Escherichia coli K12, Involvement of the glnLG and purR genes in the regulation of codA expression. Arch. Microbiol., 752:115-118, 1989.
13. Austin, E. A., and Huber, B. E. A first step in the development of gene therapy for colorectal carcinoma:cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol., 43: 380-387, 1993.
14. Steer, P. L., Marks, M. I., Klite, P. D., and Eickhoff, T. C. 5-Fluorocytosine:an oral antifungal compound. Ann. Intern. Med., 76: 15-22, 1972.
15. Rosenfeld, M. A., Siegfried. W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., Jallat, S., Pavirani, A., Lecocq, J-P., and Crystal, R. G. Adenovirus-mediated transfer of a neombinant al-antitrypsin gene to the lung epithelium in vivo. Science (Washington DC), 252; 431-434, 1991.
16. Zabner, J., Couture, L. A., Grcrory, R. J., Graham, S. M., Smith, A. E., and Welsh, M. J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell, 75:207-216, 1993.
17. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkranu, H., Couton, D., Ctrtaud, J., Briand, P., Kaplun, J-C, Perricaudet, M., and Kahn, A. Efficient adenovirus mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (Lond.), 361:647-650, 1993.
18. Hirshchowitz, E. A., Ohwada, A., Pascal, W. R., Russi, T. J., and Crystal, R. G. In vivo adenovirus-mediated gene transfer of the E. coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther., 6:1055-1063, 1995.
19. Wills, K. N., Huang, W. M., Harris, M. P., Machemer, T., Maneval, D. C., and Gregory, R. J. Gene therapy for hepatocellular carcinoma:chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther., 2: 191-197, 1995.
20. Kaneko, S., Hallenbeck, P., Kotanni, T., Nakabayashi, H., McGarrity, G., Tamaoki, T., Andersen, W. F., and Chiang, Y. L. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res., 55:5283-5287, 1995.
21. Chen, L., Chen, D., Manome, Y., Dong, Y., Fine. H. A., and Kufe, D. W. Breast cancer selective gene expression and therapy mediated by recombinant adenovirus containing the DF3/MUC promoter. J. Clin, Invest., 96:2775-2782, 1995.
22. Tanaka, T., Kanal, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Shiratori, Y., Lan, K-H., Ishitobi, M., and Omata, M. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res., 56:1341-1345, 1996.
23. Kanai, F., Shiratori, Y., Yoshida, Y., Wakimoto, H., Hamada, H., Kanegae, Y., Saito, I., Nakabayashi, H., Tamaoki, T., Tanaka, T., Lan, K-H., Kato, N., Shiina, S., and Omata, M. Gene therapy for β-fetoprotein producing human hepatoma cells by adenovirus-mediated transfer of herpes simplex virus thymidine kinase gene. Hepatology, 23:1359-1368, 1996.
24. Lan, K-H., Kanai, F., Shiratori, Y., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Tanaka, T., Ohashi, M., and Omata, M. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology, 111:1241-1250, 1996.
25. Abelev, G. I. Alpha-fetoprotein in oncogenesis and its association with malignant tumors. Adv. Cancer Res., 14: 295-358, 1971.
26. Nakabayashi, H., Hashimoto, T., Miyao, Y., Tjong, K-K., Chan, J., and Tamaoki, T. A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma. Mol. Cell. Biol., 11:5885-5893, 1991.
27. Nakata, K., Motomura, M., Nakabayashi, H., Ido, A., and Tamaoki, T. A possible mechanism of inverse developmental regulation of α-fetoprotein and albumin genes. J. Biol. Chem., 267:1331-1334, 1992.
28. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S., and Saito, I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res., 23:3816-3821, 1995.
29. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing full-length virus genome. Proc. Natl. Acad. Sci. USA, 93:1320-1324, 1996.
30. Niwa, H., Yamamura, K-I., and Miyazaki, J-I. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene, 108:193-200, 1991.
31. Zhang, W-W., Koch, P. E., and Roth, J. A. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques. 18:444-447, 1995.
32. Richards, C. A., Austin, E. A., and Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen:identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther., 6: 881-893, 1995.
33. Huber, B. E., Richards, C. A., and Krenitsky, T. A. Retroviral-mediated gene therapy for the treatment hepatocellular carcinoma:an innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA, 88: 8039-8043, 1991.
34. Marquardt, D. W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math., 2: 431-441, 1963.
35. Chang, A. G. Y., and Wu, G. Y. Gene therapy:applications to the treatment of gastrointestinal and liver diseases. Gastroenterology, 106: 1076-1084, 1994.
36. Freeman, S. M., Abboud, C. N., Whartenby. K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "neighbor cell killing effect":tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
37. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene:significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
38. Calabrisi, P., and Chabner, B. A. Antimetabolites. In:A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed., pp. 1209-1263. New York:Pergamon, 1990.
39. Petersen, D., Demertzis, S., Freund, M., Schumann, G., and Oellerich, M. Individualisation of 5-fluorocytosine therapy. Chemotherapy, 40:149-156, 1994.